The 20 Best Esophageal Cancer Doctors Near Me in San Francisco, CA

Assad Hassoun is a General Surgeon practicing medicine in San Francisco, California. Dr. Hassoun is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Hepatectomy. Dr. Hassoun is board certified in Surgery - Board Certified. Dr. Hassoun is currently accepting new patients.

Stephanie Jeske is an Oncologist practicing medicine in San Francisco, California. Dr. Jeske is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. Dr. Jeske is board certified in Medical Oncology - Board Certified and Hematology - Board Certified. Dr. Jeske is currently accepting new patients.

Dr. Johannes Kratz is a thoracic surgeon who specializes in treating disorders of the trachea, chest wall, lung, esophagus and mediastinum (the space between the lungs containing the heart and other structures). He directs UCSF's program for advanced minimally invasive thoracic surgery. Kratz's research interests include robotic surgery outcomes, lung and esophageal cancers, biomarkers to personalize lung cancer treatment and immunotherapies for thoracic tumors. His current research focuses on understanding the molecular and genetic profiles of high-risk tumors in early stages and developing targeted therapies to treat them. While a surgical research fellow at the UCSF Thoracic Oncology Laboratory, Kratz developed a test that more accurately predicts outcomes for patients with early-stage lung cancer. Now available to patients, this test has improved outcomes for those with high-risk lung cancer detected early. Kratz earned his medical degree at Harvard Medical School, graduating magna cum laude. He completed a general surgery residency at Massachusetts General Hospital, followed by a fellowship in cardiothoracic surgery at UCSF. He also has a master's degree in philosophy from Stanford University. Kratz is a member of the American College of Surgeons, Society of Thoracic Surgeons, Massachusetts Medical Society and American Society of Clinical Oncology. In 2017, he received a UCSF Health Exceptional Physician Award. He is the Van Auken Endowed Chair in Thoracic Oncology at UCSF. Dr. Kratz is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Fibrosing Mediastinitis, Thymectomy, and Endoscopy. Dr. Kratz is board certified in American Board Of Thoracic Surgery, Thoracic And Cardiac Surgery and American Board Of Surgery, General Surgery. Dr. Kratz is currently accepting new patients.

Douglas Corley is a Gastroenterologist practicing medicine in San Francisco, California. Dr. Corley is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Barrett Esophagus, Familial Colorectal Cancer, Colonoscopy, and Endoscopy.

Dr. Geoffrey Buckle is a medical oncologist who specializes in caring for patients with gastrointestinal cancers. Buckle's research focuses on improving outcomes for people with cancer in underserved settings, with a particular focus on the growing cancer burden in sub-Saharan Africa. He studies region-specific risk factors for cancer and is working on developing ways to improve early cancer detection. Buckle earned his medical degree at the University of Massachusetts Medical School. He completed a residency in internal medicine and a fellowship in medical oncology at UCSF. He also completed a master of public health degree at the Johns Hopkins Bloomberg School of Public Health. Buckle is a member of the UCSF Global Cancer Program, American Society of Clinical Oncology and African Organisation for Research and Training in Cancer. In 2022, he received a Global Oncology Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Buckle is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. His clinical expertise encompasses Esophageal Cancer, Burkitt Lymphoma, Familial Colorectal Cancer, and Stomach Cancer. Dr. Buckle is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Buckle is currently accepting new patients.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, Li-Fraumeni Syndrome, Prostatectomy, and Liver Embolization. Dr. Munster is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Munster is currently accepting new patients.

Dr. Eric Nakakura is a cancer surgeon who specializes in tumors of the liver, pancreas, bile ducts and gastrointestinal tract. He also treats soft tissue sarcomas, including tumors of the retroperitoneum (a space in the abdominal cavity), trunk and extremities. At the UCSF Helen Diller Family Comprehensive Cancer Center, he helps manage complex gastrointestinal tract cancers, soft tissue sarcomas and gastrointestinal neuroendocrine tumors, including carcinoid and islet cell tumors. In his research, Nakakura studies endocrine differentiation in gastrointestinal tumors. Nakakura earned his medical degree at Stanford University School of Medicine. He earned a doctorate in cellular and molecular medicine at Johns Hopkins University. He completed a residency in general surgery at Johns Hopkins Medicine and received advanced training in surgery at the John Radcliffe Hospital in Oxford, England. At Johns Hopkins, he completed a fellowship in surgical oncology with an emphasis on pancreatic, biliary and gastrointestinal surgery. Dr. Nakakura is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Retroperitoneal Liposarcoma, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Nakakura is board certified in American Board Of Surgery, General Surgery. Dr. Nakakura is currently accepting new patients.

Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers. Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients. Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF. Dr. Bergsland is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, Hepatectomy, and Liver Embolization. Dr. Bergsland is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Bergsland is currently accepting new patients.

Dr. Andrew H. Ko is a specialist in digestive system cancers. He provides compassionate and individualized care for patients with cancers of the pancreas, stomach and esophagus. In research, Ko has long been active in developing and evaluating new treatments for gastrointestinal cancers, including molecularly targeted agents and immune-based therapies. Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins University School of Medicine. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, and completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001. Dr. Ko is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, and Pancreatic Cancer. Dr. Ko is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ko is currently accepting new patients.

Patricia Zendejas is a nurse practitioner who helps patients manage the side effects of gastrointestinal cancer and its treatments. She educates patients and their loved ones on optimizing their quality of life while undergoing therapy, as well as during recovery. Zendejas earned her master's degree in nursing through UCSF's adult nurse practitioner program. She also has a master's degree in social work from Columbia University. Zendejas belongs to the Oncology Nursing Society and American Society of Clinical Oncology. With a particular commitment to teaching nurse practitioner students, she volunteers as a faculty member for the UCSF School of Nursing. A native of San Francisco, Zendejas grew up speaking both Spanish and English. Ms. Zendejas is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, Ampullary Cancer, Cirrhosis, and Liver Cancer. Ms. Zendejas is board certified in Oncology Nursing Certification Corporation, Advanced Oncology Certified NP. Ms. Zendejas is currently accepting new patients.

Angela Laffan is a nurse practitioner who uses a holistic approach to help patients manage symptoms of gastrointestinal cancer and side effects of its treatments. She also educates patients on how to improve their health and quality of life, and how to reduce their risk of cancer recurrence. She has more than 25 years of experience in oncology nursing. Laffan earned her master's degree from UCSF's adult-gerontology nurse practitioner program, with a subspecialty in integrative medicine. She is a member of the Oncology Nursing Society. Ms. Laffan is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Gastroesophageal Junction Cancer, Ampullary Cancer, Liver Cancer, and Stomach Cancer. Ms. Laffan is board certified in American Nurses Credentialing Center - Adult NP, Adult Nurse Practitioner. Ms. Laffan is currently accepting new patients.

Dr. Luai Al Rabadi is a medical oncologist who specializes in caring for patients with cancers of the digestive system. In his research, Al Rabadi focuses on improving cancer outcomes by studying prevention strategies, new therapies, and trends in how patients receive care. His research aims to provide patients with more effective and personalized treatment options. Al Rabadi earned his medical degree from the Royal College of Surgeons in Ireland. He completed a residency in internal medicine at MetroHealth Medical Center, an affiliate of Case Western Reserve University. He completed a fellowship in hematology and medical oncology at Oregon Health & Science University. Outside of work, Al Rabadi enjoys spending time with family, being outdoors, and watching and playing soccer. Dr. Rabadi is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. His clinical expertise encompasses Colorectal Cancer, Lynch Syndrome, Familial Colorectal Cancer, and Acute Monoblastic Leukemia (AmoL). Dr. Rabadi is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Med/Medical Oncology, Medical Oncology, and American Board Of Internal Medicine, Internal Medicine. Dr. Rabadi is currently accepting new patients.

Gabriel Schwartz is a nurse practitioner who manages symptoms and side effects of anticancer therapies for adults with gastrointestinal cancers. He helps patients maximize their quality of life during all stages of their journey, from diagnosis to treatment and life after treatment. With those who are newly diagnosed, he explores strategies for supportive care, such as interventions for treating nausea and pain. In research, Schwartz has an interest in clinical trials of promising new cancer therapies and therapies for cancer symptom management. Schwartz earned a bachelor's degree in chemistry from Haverford College and a bachelor's degree in nursing from the University of Pennsylvania, where he graduated summa cum laude. He then earned a master's degree in nursing through the school's family nurse practitioner program. Prior to joining UCSF, Schwartz worked for 12 years caring for patients as well as contributing to research in cancer care and emergency medicine. He once earned a commendation from the Pennsylvania legislature for assisting with the successful delivery of breech-birth twins outside the hospital setting. He belongs to the Oncology Nursing Society and Alameda County Medical Reserve Corps. Schwartz lives in the East Bay with his wife and dog. In his free time, he enjoys cooking, hiking and camping. He is a native Spanish speaker. Mr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. His clinical expertise encompasses Gallbladder Adenocarcinoma, Liver Cancer, Stomach Cancer, and Esophageal Cancer. Mr. Schwartz is board certified in Oncology Nursing Certification Corporation, Advanced Oncology Certified NP. Mr. Schwartz is currently accepting new patients.

Dr. Margaret Tempero is a gastrointestinal oncologist and the director of the UCSF Pancreas Center and leader of the Pancreas Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center. In research, Tempero was a pioneer in applying radioactively tagged antibodies for cancer therapy. She has led national research projects on gastrointestinal cancers, including pancreatic cancer. Tempero has held editorial positions on such prestigious journals as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Medicine. She is the Rombauer Family Distinguished Professor in Pancreas Cancer Clinical and Translational Science. Prior to joining UCSF, she was deputy director of the University of Nebraska's cancer center. Dr. Tempero is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatoblastoma, and Pancreatectomy. Dr. Tempero is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Med/Medical Oncology, Medical Oncology, and American Board Of Internal Medicine, Internal Medicine. Dr. Tempero is currently accepting new patients.

Dr. Katherine Van Loon is a specialist in gastrointestinal cancers, with a particular interest in colon cancer. With a background in public health, Van Loon's research is focused on epidemiology – the study of which populations develop diseases and which factors contribute – as well as outcomes in gastrointestinal malignancies. She has a long-standing interest in global health and has also studied the epidemiology of gastrointestinal cancers in the developing world. Van Loon earned her master's degree in public health from the Yale School of Public Health before attending the Medical College of Georgia. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School. She came to UCSF for a fellowship in oncology in 2009. Van Loon is a member of the American Society of Clinical Oncology (ASCO). She received a Young Investigator Award from the ASCO Conquer Cancer Foundation in 2012. Dr. Van Loon is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Gastroesophageal Junction Cancer. Dr. Van Loon is board certified in American Board Of Medical Specialties, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Van Loon is currently accepting new patients.

Dr. R. Kate Kelley is a gastrointestinal oncologist who treats liver cancers such as hepatocellular carcinoma; bile duct cancer (cholangiocarcinoma); gastric cancer; esophageal cancer; anal, colon and rectal cancer; pancreatic cancer; and gastrointestinal stromal tumors. Kelley's research interests include developing clinical trials to identify new treatments for gastrointestinal malignancies, particularly hepatocellular carcinoma and bile duct cancer. Kelley graduated from the David Geffen School of Medicine at UCLA and completed a residency at UCLA, where she was chief resident in internal medicine. She also completed a fellowship in hematology and oncology at UCSF. Kelley received the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium Merit Award in 2009 and the ASCO Young Investigator Award in 2010. She co-authored a chapter on digestive tract cancers in the textbook Current Medical Diagnosis and Treatment. Dr. Kelley is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Adenocarcinoma, and Gallbladder Cancer. Dr. Kelley is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Kelley is currently accepting new patients.

Eric Collisson is an Oncologist practicing medicine in San Francisco, California. Dr. Collisson is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Tissue Biopsy, and Pancreatectomy.

Dr. Tammy T. Chang is a surgeon who specializes in gastrointestinal conditions as well as urgent conditions requiring prompt treatment. Chang directs a research laboratory that focuses on liver tissue engineering and regenerative surgical therapies, which stimulate the formation of new tissue. Chang earned her combined medical and doctoral degrees at Harvard Medical School. She completed her general surgery residency at UCSF, followed by her fellowship in minimally invasive gastrointestinal surgery. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. Her clinical expertise encompasses Pancreatic Cancer, Ogilvie Syndrome, Retroperitoneal Inflammation, Small Bowel Resection, and Gallbladder Removal. Dr. Chang is board certified in American Board Of Surgery, Surgery. Dr. Chang is currently accepting new patients.

Dr. Jonathan Carter is a surgeon who specializes in minimally invasive, advanced approaches such as laparoscopic and robotic surgery to treat abdominal conditions. He cares for patients with hernias and disorders of the esophagus, gallbladder, stomach and intestines. He is also a bariatric surgeon and a member of the acute care surgery program, which provides surgical care in emergencies. After earning his medical degree at Stanford University School of Medicine, Carter completed a residency in surgery and a fellowship in advanced laparoscopic and bariatric surgery at UCSF. Carter is a fellow of the American College of Surgeons and American Society for Metabolic and Bariatric Surgery. As a UCSF faculty member, Carter has authored more than 60 peer-reviewed research papers in the subject areas of esophageal disease, bariatric surgery, hernia and medical information science. Carter received the 2008 and 2015 UCSF Haile T. Debas Academy of Medical Educators' Excellence in Teaching Awards, as well as UCSF's annual patient safety award in 2014 and 2016. He received the Julius R. Krevans Award for patient care at UCSF, as well as the prestigious Fred H. and Esther E. Nusz Achievement Award. See a UCTV video of Carter, who discusses Obesity in America – Diet, Drugs or Surgery . Dr. Carter is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hernia, Obesity, Gallstones, Hernia Surgery, and Vagotomy. Dr. Carter is board certified in American Board Of Surgery, General Surgery. Dr. Carter is currently accepting new patients.

Dr. Hobart W. Harris is an expert in treating surgical infections and diseases of the pancreas and biliary system. He cares for patients with complicated and often life-threatening conditions in the Complex Abdominal Surgery Program . His areas of expertise include pancreas and bile duct cancer, acute and chronic pancreatitis, islet cell transplantation for pancreatitis, gallstone disease, intra-abdominal sepsis and serious infections of the skin and soft tissue. Harris research focuses on surgical infections, innate immunity and inflammatory diseases of the pancreas. Harris earned his undergraduate and medical degrees, as well as a master of public health degree, at Harvard University. He completed a residency in surgery at UCSF, followed by a fellowship in hepatobiliary surgery at the University of Hong Kong, Queen Mary Hospital. He joined UCSF in 1994. Harris is a fellow of the American College of Surgeons. He is a member of numerous surgical and scientific societies, including the American Surgical Association. Dr. Harris is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Hernia, Childhood Pancreatitis, Chronic Pancreatitis, Hernia Surgery, and Pancreatectomy. Dr. Harris is board certified in American Board Of Surgery, General Surgery. Dr. Harris is currently accepting new patients.